Upcoming Earnings: Q2 '26
Estimated EPS
-$0.08
Estimated Rev
$13.18M
$APYX Q1 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.05 up 50.00% YoY • Reported revenue of $12.49M up 32.45% YoY • Apyx Medical raised its total revenue guidance for FY2026 to $59M to $60M, up from $57.5M to $58.5M, and expects operating expenses to be less than $45M for the year.
Generated by Stocktwits using AI and company-reported earnings data for Q2 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.
Historical Earnings
Quarterly
Annual
EPS
Revenue
| Fiscal Period | Estimated | Reported | Surprise | Result |
|---|---|---|---|---|
Q2 '26 | -$0.08 | -- | -- | N/A |
Q1 '26 | -$0.11 | -$0.05 | 54.55% | BEAT |
Q4 '25 | -$0.05 | -$0.03 | 38.40% | BEAT |
Q3 '25 | -$0.10 | -$0.05 | 51.16% | BEAT |
Q2 '25 | -$0.09 | -$0.09 | 3.57% | BEAT |